Colonization, serotypes and transmission rates of group B streptococci in pregnant women and their infants born at a single University Center in Germany

Journal of Perinatal Medicine

Volumn 39, Issue 4, 2011, Pages 417-422

  Kunze, Mirjam ^a   Ziegler, Anna ^a   Fluegge, Kirsten ^a   Hentschel, Roland ^a   Proempeler, Heinrich ^a   Berner, Reinhard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Colonization; early onset GBS disease; group B streptococci; intrapartum prophylaxis; serotypes; transmission

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; STREPTOGRAMIN;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CESAREAN SECTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; EAR; EARLY ONSET DISEASE; FEMALE; GERMANY; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INFANT; INTRAPARTUM CARE; MAJOR CLINICAL STUDY; NEWBORN; ONSET AGE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SEROTYPE; SEROTYPING; SINGLE DRUG DOSE; STREPTOCOCCUS AGALACTIAE; UNIVERSITY HOSPITAL; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 79960276294     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.037     Document Type: Article

References (26)

1. American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptoccal disease in newborns. ACOG Committee Opinion N. 279. Obstet Gynecol. 2002;100:1405-12.
2. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1665-9. (Pubitemid 16097843)
3. Brimil N, Barthell E, Heindrichs U, Kuhne M, Lütticken R, Spellerberg B. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol. 2006;296:39-44. (Pubitemid 43089716)
4. Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. Br Med J. 2007;335:655-61.
5. Early-onset group B streptococcal disease, United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 2000;49: 793-6.
6. Fluegge K, Supper S, Siedler A, Berner R. Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin Infect Dis. 2005;40:760-3. (Pubitemid 40381355)
7. Gibbs RS, Schrag S, Schuchat A. Perinatal infections due to group B Streptococci. Obstet Gynecol. 2004;104:1062-76. (Pubitemid 40458775)
8. Giovanetti E, Montanari MP, Mingoia M, Varaldo PE. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother. 1999;43: 1935-40. (Pubitemid 29395189)
9. Hong JS, Choi CW, Park KU, Kim SN, Lee HJ, Lee HR, et al. Genital group B streptococcus carrier rate and serotype distribution in Korean pregnant women: implications for group B streptococcal disease in Korean neonates. J Perinat Med. 2010;38:373-7.
10. Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006;4:932-42. (Pubitemid 44768255)
11. Matteson KA, Lievense SP, Catanzaro B, Phipps MG. Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy. Obstet Gynecol. 2008;111:356-64. (Pubitemid 351653426)
12. Montanari MP, Mingoia M, Giovanetti E, Varaldo E. Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. J Clin Microbiol. 2001;39:1311-5. (Pubitemid 32275426)
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Supplement M 100-S13: National Committee for Clinical Laboratory Standards, Wayne, 2003.
14. Panda B, Iruretagoyena I, Stiller R, Panda A. Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci. J Matern Fetal Neonatal Med. 2009;22:111-4.
15. Prophylaxe der Neugeborenensepsis-frühe Form-durch Streptokokken der Gruppe B. AWMF-Leitlinien-Register Nr.024/ 020. 1996. Last update 08/2008.
16. Ramus RM, McIntire DD, Wendel GD Jr. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term wAbstractx. Am J Obstet Gynecol. 1999;180:S85.
17. Rausch AV, Gross A, Droz S, Bodmer T, Surbeck DV. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis. J Perinat Med. 2009; 37:124-9.
18. Regan JA, Klebanoff MA, Nugent RP. Vaginal infections and prematurity study group. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol. 1991;77: 604-10.
19. Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 1993;169:839-51. (Pubitemid 23317515)
20. Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease. RCOG Guideline 2003;36:1-10.
21. Savoia D, Gottimer C, CrocillaC, Zucca M. Streptococcus agalactiae in pregnant women. Phenotypic and genotypic characters. J Infect. 2008;56:120-5.
22. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20. (Pubitemid 30020655)
23. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11:497-513. (Pubitemid 28379097)
24. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996;40:2562-6. (Pubitemid 26367644)
25. Von Both U, Buerckstuemmer A, Fluegge K, Berner R. Heterogeneity of genotype-phenotype correlation among macrolide- resistant Streptococcus agalactiae isolates. Antimicrob Agents Chemother. 2005;49:3080-2. (Pubitemid 40917647)
26. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis. 2004;38:1203-8. (Pubitemid 38608558)